About this collection
A new era in T1D management
This educational program provides the essential framework to transform T1D into a more predictable and manageable condition for your patients, with opportunity for proactive support measures or care.
Identify risk, prevent crisis
Grasp the new understanding of T1D as a staged autoimmune disease. By using simple screening to identify individuals in the long pre-symptomatic phase, you can prevent the trauma of DKA and shift families from an emergency response to a planned, supported healthcare journey.
A clinical framework for action
This program delivers more than theory. You will gain the clinical tools to act, including the new international consensus guidelines for monitoring, which were recently released – with several steering committee members contributing. You will also learn about the application of disease modifying therapies, such as teplizumab (currently approved in select countries such as the US and Canada), that can help to delay disease progression, preserve beta-cell function, and provide a better quality of life for your patients.
Let's change the landscape of T1D.
WEBINAR FOR GENERAL PRACTICE - inc. Q&A
Now available on-demand
Description:
Early stage type 1 diabetes (T1D) is a critical yet poorly understood phase preceding clinical diagnosis. With 90% of diagnoses occurring without a family history, many individuals progress silently through islet autoimmunity until presenting with life-threatening diabetic ketoacidosis (DKA).
This webinar provides a case-based approach to navigating the GP's role in early identification and shared care. Using a single case study followed across key decision points, clinical experts will guide you through pre-test counselling, interpreting islet autoantibodies, and applying the international three-stage framework. You will learn to identify high-risk phenotypes, establish evidence-based monitoring cadences, and recognise urgent "red flags" for specialist referral. The session also explores emerging disease-modifying therapies and practical strategies to reduce diagnostic delay, equipping you to support families with clarity and confidence.
Learning outcomes:
-
Apply a structured GP approach to early stage T1D across key clinical decision points to guide when to test, how to counsel, and when to refer.
-
Interpret autoantibody and baseline glycaemic results in context, recognising which findings require routine referral, urgent escalation, or ongoing shared care, and avoiding common management gaps after results are returned.
-
Support patients and families once specialist care is established, including communicating risk, managing uncertainty and anxiety, and responding appropriately to questions and concerns.
Presenters:
Dr Sarah Black
Endocrinologist
Dr Richard Liu
Endocrinologist
Dr Anita Sharma
GP and Medical Educator
Description:
General practitioners play a vital role in addressing the alarming reality that one-third of Australian children first present with life-threatening diabetic ketoacidosis, while many adults endure prolonged metabolic decompensation due to frequent misdiagnosis as having type 2 diabetes.
By engaging with this education, you will learn to accurately classify patients using the international three-stage framework, implement proactive shared-care monitoring plans that recognise urgent red flags, and utilise person-first communication strategies to effectively support families facing the significant psychosocial burden of a type 1 diabetes risk identification.
Learning outcomes:
-
Identify individuals at increased risk of T1D and determine when islet autoantibody testing is clinically indicated.
-
Apply the internationally recognised staging framework for early-stage T1D (Stages 1–3) to support accurate classification and timely action.
-
Develop and implement an appropriate monitoring and referral plan for children and adults with islet autoimmunity.
-
Communicate risk and uncertainty clearly to individuals and families to support preparedness and psychosocial wellbeing.
Dr Sarah Black
Endocrinologist
Dr Richard Liu
Endocrinologist
Dr Anita Sharma
GP and Medical Educator
Description:
Endocrinologists are at the forefront of a paradigm shift in diabetes care, moving from reactive insulin management to the proactive identification of patients in the pre-symptomatic phase. This transition is critical to addressing the reality that one-third of Australian children still first present in life-threatening ketoacidosis, and to facilitating timely access to emerging immunotherapy trials.
By engaging with this education, you will refine your ability to risk-stratify patients using the international staging framework, coordinate sophisticated monitoring protocols—including the use of HbA1c and CGM metrics—and lead multidisciplinary care that addresses the complex psychosocial needs of families navigating a lifelong risk identification.
Learning outcomes:
-
Describe the foundations of early stage T1D, including its pathophysiology, clinical progression through identifiable stages, and the rationale for screening.
-
Apply best-practice screening protocols to assess progression risk and identify appropriate referral pathways.
-
Implement effective, family-centred communication strategies to address the psychosocial impacts of the diagnosis.
-
Develop a guideline-based monitoring and education plan for a family with early stage T1D, incorporating appropriate glycaemic monitoring and providing clear advice on when to seek medical care to prevent DKA.
-
Explain the rationale for emerging therapies and assess a patient's eligibility for relevant Australian clinical trials.
Dr Sarah Black
Endocrinologist
Dr Richard Liu
Endocrinologist
Dr Anita Sharma
GP and Medical Educator
eLEARNING MODULE FOR CDEs
_edited.png)
Description:
This module explores the shifting Type 1 diabetes (T1D) landscape, moving from symptomatic diagnosis to the identification of early, pre-symptomatic stages. Designed for Credentialled Diabetes Educators (CDEs), it covers the complexities of autoantibody screening, risk stratification, and the psychosocial challenges of a "pre-diagnosis". You will learn to translate pathophysiology into family-appropriate language while guiding patients through monitoring and clinical trial participation.
Through practical case scenarios, the module demonstrates how to provide stage-appropriate education to reduce DKA risk and empower informed decision-making. Participants will gain strategies for managing family anxiety, coordinating multidisciplinary care, and reinforcing evidence-based messages across the T1D continuum. This training ensures CDEs remain a vital support point as families navigate the evolving realities of T1D prevention and early intervention.
Learning outcomes:
-
Recognise individuals and families who may be at increased risk of T1D, and support appropriate education, discussion, and referral regarding islet autoantibody testing in collaboration with the medical team.
-
Explain the internationally recognised staging framework for early stage T1D (stages 1–3) in clear, patient-centred language to support understanding, expectation setting, and ongoing engagement with monitoring and care.
-
Support monitoring and follow-up for children and adults with islet autoimmunity by reinforcing agreed care plans, recognising changes that warrant escalation, and coordinating referrals within the multidisciplinary team.
-
Communicate risk, uncertainty, and progression sensitively and effectively to individuals and families, using strategies that support preparedness, reduce distress, and promote psychosocial wellbeing over time.
Dr Sarah Black
Endocrinologist
Dr Richard Liu
Endocrinologist
Dr Anita Sharma
GP and Medical Educator
Patient handout kits coming soon...
To support clinicians' consultations with patients, families and carers on pre-T1D diagnosis, Breakthrough T1D is currently developing a range of online resources.
To receive updates on when these resources become available, pre-register here.
Steering committee
Continuing Professional Development (CPD) Details
This medical education collection is being developed to Australian medical CPD standards and will offer learners a combination of Educational Activity, Reviewing Performance and Measuring Outcomes education.
See individuial activities for relevant accreditation details.
Certificates of completion will be available to learners upon successful completion of each activity.
.webp)
Praxhub is an accredited Major Provider under the RACGP CPD Program.
Praxhub acknowledges Breakthrough T1D (Formerly JDRF) for its support of this education.
Register your interest in this T1D education
This groundbreaking education is coming very soon. Be the first to hear about it when it does! By registering your interest below we'll let you know as soon as it's available in Praxhub.
Unless additional consent is granted, the details provided by you will only be used for the purpose of notifying you when these activities and resources become available. If you have questions regarding the collection or use of your information, please contact privacy@praxhub.com.
References:
1. Breakthrough T1D, https://breakthrought1d.org.au/what-is-t1d/quick-guide-to-t1d/